文献速递瓣膜外科

二尖瓣手术联合Cox-maze术后1年内永久起搏器植入对预后的影响

Prognostic impact of 1-year permanent pacemaker implantation after mitral valve surgery with the Cox-maze procedure.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

结果显示起搏器植入与长期死亡率及缺血性卒中风险无显著相关,但与感染性心内膜炎风险显著增加相关。

要点

  • 术后1年内永久起搏器植入不显著增加长期死亡率或缺血性卒中风险。
  • 永久起搏器植入与感染性心内膜炎风险显著增加相关(HR 2.015)。
  • Cox-maze术仍建议用于接受二尖瓣手术的房颤患者。

核心结论

  • 二尖瓣手术联合Cox-maze术后1年内植入永久起搏器不显著影响长期死亡率或缺血性卒中风险,但与感染性心内膜炎风险增加相关。

主要发现

  • 总队列中178例(1.76%)植入永久起搏器。
  • 随访期间总死亡率为20.5%,PPM组与非PPM组无显著差异。
  • 永久起搏器植入不是总死亡率的显著危险因素(HR 0.825;95%CI 0.598-1.140;P=0.244)。
  • 永久起搏器植入与感染性心内膜炎风险显著增加相关(HR 2.015;95%CI 1.179-3.442;P=0.010)。

临床怎么用

  • 对于接受二尖瓣手术的房颤患者,Cox-maze术仍建议施行。
  • 术后1年内植入永久起搏器的患者需关注感染性心内膜炎风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to evaluate the prognostic impact of permanent pacemaker (PPM) implantation within the first year after mitral valve (MV) surgery combined with the Cox-maze procedure, focusing on long-term outcomes, including overall mortality, infective endocarditis (IE) and ischaemic stroke. METHODS: We conducted a retrospective cohort study using data from the National Health Insurance Service (NHIS) in South Korea, identifying 10 127 patients who underwent MV surgery with the Cox-maze procedure between 2005 and 2020. Patients were classified into the PPM and non-PPM groups based on PPM implantation within 1 year postoperatively. The primary outcome was overall mortality, and secondary outcomes included risk factors for overall mortality, IE and ischaemic stroke. Multivariable Cox proportional hazards regression and Fine-Gray competing risk models were utilized for statistical analysis. RESULTS: Of the total cohort, 178 patients (1.76%) underwent PPM implantation. The overall mortality during the follow-up period was 20.5%, with no significant difference between the PPM and non-PPM groups. PPM implantation was not a significant risk factor for overall mortality (hazard ratio [HR], 0.825; 95% confidence interval [CI] 0.598-1.140; P = 0.244) or ischaemic stroke. However, PPM implantation was associated with a significantly increased risk of IE (HR, 2.015; 95% CI 1.179-3.442; P = 0.010). CONCLUSIONS: PPM implantation within the first year after MV surgery with the Cox-maze procedure does not significantly impact long-term mortality or ischaemic stroke risk but is associated with an increased risk of IE. The Cox-maze procedure remains advisable for patients with atrial fibrillation undergoing MV surgery.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Lee JH, Kim YJ, Kim JE, et al. Prognostic impact of 1-year permanent pacemaker implantation after mitral valve surgery with the Cox-maze procedure. Eur J Cardiothorac Surg. 2025. PMID: 39878876. doi:10.1093/ejcts/ezaf018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。